Immunomodulatory effects of moxifloxacin in human respiratory tract infection

K. Rohmann, S. Demedts, M. Schwendt, D. Droemann, T. Goldmann, J. Rupp, K. Dalhoff (Luebeck, Germany)

Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Session: Treatment and risk factors in lower respiratory tract infections
Session type: E-Communication Session
Number: 5192
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Rohmann, S. Demedts, M. Schwendt, D. Droemann, T. Goldmann, J. Rupp, K. Dalhoff (Luebeck, Germany). Immunomodulatory effects of moxifloxacin in human respiratory tract infection. Eur Respir J 2010; 36: Suppl. 54, 5192

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of antibiotics therapy for low respiratory tract infections
Source: Eur Respir J 2007; 30: Suppl. 51, 406s
Year: 2007

Intrapulmonary penetration of antimicrobials and implications in treatment of lower respiratory tract infections
Source: Annual Congress 2009 - Antibiotics and the lung
Year: 2009


Treatment of respiratory tract infections: comparison of telithromycin and azithromycin
Source: Eur Respir J 2004; 24: Suppl. 48, 638s
Year: 2004

Pharmacological interactions between antibiotics and other drugs in the treatment of lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=229
Year: 2004

Pharmacokinetics and pharmacodynamics of newer fluoroquinolones in patients with lower respiratory tract infections
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

Efficacy and safety of Cefdinir in lower respiratory tract infections
Source: Eur Respir J 2002; 20: Suppl. 38, 420s
Year: 2002

Antibiotic switch therapy in lower respiratory tract infections
Source: Annual Congress 2009 - Antibiotics and the lung
Year: 2009


Lower respiratory tract infections: bacteria and virus, antibiotics and steroids
Source: Annual Congress 2008 - Infection year in review
Year: 2008


Telithromycin is as effective as comparator antibacterials in the treatment of lower respiratory tract infections
Source: Eur Respir J 2002; 20: Suppl. 38, 561s
Year: 2002

Does antibiotic treatment of upper respiratory tract infections prevent bacterial LRTIs?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009



Streptococcal resistance to antibiotics in children with upper respiratory tract infections. Epidemiological aspects
Source: Annual Congress 2010 - Paediatric respiratory infection, inflammation and immunology
Year: 2010

Bacterial agents of community-acquired lower respiratory tract infections: observational study on antimicrobial drugs susceptibility
Source: Eur Respir J 2002; 20: Suppl. 38, 421s
Year: 2002

Viral agents in children with lower respiratory tract infection
Source: Eur Respir J 2006; 28: Suppl. 50, 487s
Year: 2006

Telithromycin is highly efficacious in the treatment of lower respiratory tract infections
Source: Eur Respir J 2003; 22: Suppl. 45, 151s
Year: 2003

Influence of antibiotic resistance of pseudomonas aeruginosa on presenting features of community-acquired lower respiratory tract infections
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011


Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85
Source: Eur Respir Rev 2005; 14: 74-77
Year: 2005



Intrapulmonary penetration of antimicrobials and implications in the treatment of lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=13
Year: 2004

Role of α- and β-defensins in lower respiratory tract infections
Source: Annual Congress 2007 - Aetiology, mechanisms and treatment in lower respiratory tract infections
Year: 2007


Population pharmacokinetics and pharmacodynamics analysis of vancomycin in patients with severe lower respiratory tract gram-positive infections
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Bacterial profile, antibiotic sensitivity and resistance of lower respiratory tract infections in upper Egypt
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011